Shawn Kwatra, MD, and Peter Lio, MD, discuss new developments in atopic dermatitis (AD) treatments, including promising topical medications like roflumilast and tapinarof, and the role of microbiome modulation in AD management through diet and probiotics. They emphasize the holistic approach to AD treatment, integrating conventional medicine with traditional practices and the growing potential of nutraceuticals.

Reference: Kwatra S, Lio P. Prospective Therapies for AD. Dermatology Times. Updated July 19, 2023. Accessed December 28, 2023. https://www.dermatologytimes.com/view/prospective-therapies-for-ad